5Mineta M, Hatori M, Sano H, et al. Recurrent Crow- Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature[ J]. Tohoku J Exp Med, 2006,210 ( 3 ) : 269-277.
6Watanabe O, Maruyama I, Arimura K, et al. Overpro- duction of vascular endothelial growth factor/vascular per- meability factor is causative in Crow-Fukase (POEMS)syndrome[ J]. Muscle Nerve, 1998,21:1390-1397.
7Soubrier M, Dubost J J, Serre A F, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor[ J]. Arthritis Rheumatism, 1997,40:786-787.
8Soubrier M J, Dubost J J, Sauvezie B J. POEMS syn- drome : a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome [ J]. Am J Med, 1994,97(6) :543-553.
9Nakanishi T, Sobue I, Toyokura Y, et al. The Crow- Fukase syndrome: a study of 102 cases in Japan [ J ]. Neurology, 1984,34(6) :712-720.
10Li J, Zhang W, Li J, et al. Combination of melphalan and dexa-methasone for patients with newly diagnosed POEMS syndrome [ J ]. Blood, 2011,117 ( 24 ) : 6445-6449.
